Letter to the Editor
Impacting Global Health Delivery Through Advocacy: The Case of Losartan
Abstract
Highlights
- The WHO’s EML improves medicine access.
- Anyone can lobby to add a medicine to the EML, so we added losartan in 2017.
- Evidence now shows losartan is more impactful than previously realized.
- You too can use the EML to effect policy change—by adding to or amending it.
- Also, you can hold governments accountable to keep EML medicines on their shelves.
Published on Mar 1, 2019